دورية أكاديمية

Decreased enrollment in breast cancer trials by histologic subtype: does invasive lobular carcinoma resist RECIST?

التفاصيل البيبلوغرافية
العنوان: Decreased enrollment in breast cancer trials by histologic subtype: does invasive lobular carcinoma resist RECIST?
المؤلفون: Abel, Mary Kathryn, Melisko, Michelle E., Rugo, Hope S., Chien, A. Jo, Diaz, Italia, Levine, Julia K., Griffin, Ann, McGuire, Joseph, Esserman, Laura J., Borno, Hala T., Mukhtar, Rita A.
المصدر: npj Breast Cancer ; volume 7, issue 1 ; ISSN 2374-4677
بيانات النشر: Springer Science and Business Media LLC
سنة النشر: 2021
مصطلحات موضوعية: Pharmacology (medical), Radiology, Nuclear Medicine and imaging, Oncology
الوصف: Enrollment in metastatic breast cancer trials usually requires measurable lesions, but patients with invasive lobular carcinoma (ILC) tend to form diffuse disease. We found that the proportion of patients with metastatic ILC enrolled in clinical trials at our institution was significantly lower than that of patients with invasive ductal carcinoma (IDC). Possible links between requiring measurable disease and decreased enrollment of ILC patients require further study to ensure equitable trial access.
نوع الوثيقة: article in journal/newspaper
اللغة: English
DOI: 10.1038/s41523-021-00348-z
الإتاحة: https://doi.org/10.1038/s41523-021-00348-zTest
https://www.nature.com/articles/s41523-021-00348-z.pdfTest
https://www.nature.com/articles/s41523-021-00348-zTest
حقوق: https://creativecommons.org/licenses/by/4.0Test ; https://creativecommons.org/licenses/by/4.0Test
رقم الانضمام: edsbas.904C6083
قاعدة البيانات: BASE